Trastuzumab induced in vivo tissue remodelling associated in vitro with inhibition of the active forms of AKT and PTEN and RhoB induction in an ovarian carcinoma model

BACKGROUND: The incidence of ovarian cancer has been increasing worldwide and it is currently the leading cause of death from gynaecological malignancy. Unlike breast cancer, the prognostic role of the human epidermal growth factor receptor-2 (HER-2) in ovarian carcinoma remains controversial. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Delord, J-P, Quideau, S, Rochaix, P, Caselles, O, Couderc, B, Hennebelle, I, Courbon, F, Canal, P, Allal, B C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905299/
https://www.ncbi.nlm.nih.gov/pubmed/20588279
http://dx.doi.org/10.1038/sj.bjc.6605699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905299/
https://www.ncbi.nlm.nih.gov/pubmed/20588279
http://dx.doi.org/10.1038/sj.bjc.6605699

Ejemplares similares